LASP1 and breast carcinoma: In the present study, we identified LASP1 as a direct target of miR-203a-3p in nasopharyngeal carcinoma, in agreement with previous findings in head and neck cancer, breast cancer, esophageal carcinoma, prostate and lung cancers [22–28].